2,970
Views
45
CrossRef citations to date
0
Altmetric
Research Article

Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery

&
Pages 215-222 | Received 07 Jun 2010, Accepted 12 Nov 2010, Published online: 12 Jan 2011

References

  • Akbuğa, J., Aral, C., Özbaş-Turan, S., Kabasakal, L., Keyer-Uysal, M. (2003). Transfection efficiency of chitosan microspheres effect of DNA topology. STP Pharm Sci. 13:99–103.
  • Akbuğa J, Özbaş-Turan S. (2006). Comparison of chitosan-based systems for skin gene delivery. XIVth Annual Congress of The European Society for Gene Therapy, Athens, Greece, 9–12 November.
  • Akbuğa, J., Özbaş-Turan, S., Erdoğan, N. (2004). Plasmid-DNA loaded chitosan microspheres for in vitro IL-2 expression. Eur J Pharm Biopharm. 58:501–7.
  • Alexander, M.Y., Akhurst, R.J. (1995). Liposome-mediated gene transfer and expression via the skin. Hum Mol Genet. 4:2279–85.
  • Aral, C., Özbaş-Turan, S., Kabasakal, L., Keyer-Uysal, M., Akbuğa, J. (2000). Studies of effective factors of plasmid DNA-loaded chitosan microspheres: I. Plasmid size, chitosan concentration and plasmid addition technique. STP Pharm Sci. 10:83–8.
  • Badea, I., Wettig, S., Verrall, R., Foldvari, M. (2007). Topical non-invasive gene delivery using gemini nanoparticles in interferon γ deficient. EJPB. 65:414–22.
  • Bancroft, J.D., Gamble, M. (2003). Theory and practice of histological techniques. 5th ed. Edinburgh, London: Churchill Livingstone.
  • Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–54.
  • Brand, R.M., Iversen, P.L. (2000). Transdermal delivery of antisense compounds. Adv Drug Del Rev. 44:51–7.
  • Calvo, P., Remunan-Lopez, C., Vila Jato, J.L., Alonso, M.J. (1997). Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 14:1431–6.
  • Csaba, N., Köping-Höggård, M., Alonso, M.J. (2009). Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int J Pharm. 382:205–14.
  • Cui, Z., Mumper, R.J. (2001). Chitosan-based nanoparticles for topical genetic immunization. J Contr Rel. 75:409–19.
  • Cui, Z., Mumper, R.J. (2002). Topical immunization using nanoengineered genetic vaccines. J Contr Rel. 81:173–84.
  • Domashenko, A., Gupta, S., Cotsarelis, G. (2000). Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex. Nat Biotechnol. 18:420–3.
  • Elias, P.M., Cooper, E.R., Korc, A., Brown, B.E. (1981). Percutaneous transport in relation to stratum corneum structure and lipid composition. J Invest Dermatol. 76:297–301.
  • Fan, H., Lin, O., Morrissev, G.R., Khavari, P.A. (1999). Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol. 17:870–2.
  • Fernandez-Urrusuno, R., Calvo, P., Remunan-Lopez, C., Vila Jato, J.L. (1999). Chitosan nanoparticles: a new vehicle for increasing the nasal absorption of peptides. Proceed Intern Symp Control Rel Bioact Mater. 26:353–4.
  • Gan, Q., Wang, T., Cochrane, C., McCarron, P. (2005). Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloid Surfaces B. 44:65–73.
  • Hengge, U.R., Pfützner, W., Williams, M., Goos, M., Vogel, J.C. (1998). Efficient expression of naked plasmid DNA in mucosal epithelium: Prospective for the treatment of skin lesions. J Invest Dermatol. 111:605–8.
  • Hengge, U.R., Walker, P.S., Vogel, J.C. (1996). Expression of naked DNA in human, pig, and mouse skin. J Clin Invest. 97:2911–6.
  • Hofmann, U., Tokura, Y., Nishijima, T., Takigawa, M., Paus, R. (1996). Hair cycle-dependent changes in skin immune functions: anagen-associated depression of sensitization for contact hypersensitivity in mice. J Invest Dermatol. 106:598–604.
  • Issa, M.M., Koping-Hoggard, M., Tommeraas, K., Varum, K.M., Christensen, B.E., Strand, S.P., Artursson, P. (2006). Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo. J Contr Rel. 28:103–12.
  • Jayakumar, R., Chennazhi, K.P., Muzzarelli, R.A.A., Tamura, H., Nair, S.V., Selvamurugan, N. (2010a). Chitosan conjugated DNA nanoparticles in gene therapy. Carbohydr Polym. 79:1–8.
  • Jayakumar, R., Menon, D., Manzoor, K., Nair, S.V., Tamura, H. (2010b). Biomedical applications of chitin and chitosan based nanomaterials-A short review. Carbohydr Polym. 82:227–32.
  • Kohli, A.K., Alpar, H.O. (2004). Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharmceut. 275:13–7.
  • Koping-Hoggard, M., Mel’nikova, Y.S., Varum, K.M., Lindman, B., Artursson, P. (2003). Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo. J Gene Med. 5:130–41.
  • Koping-Hoggard, M., Tubulekas, I., Guan, H., Edwards, K., Nilsson, M., Varum, K.M., Artursson, P. (2001). Chitosan as a nonviral gene delivery system. Structure-property relationship and characteristics compared with polyethyleneimine in vitro and after lung administration in vivo. Gene Ther. 8:1108–21.
  • Koping-Hoggard, M., Varum, K.M., Issa, M.M., Danielsen, S., Christensen, B.E., Stokke, B.T., Artursson, P. (2004). Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 11:1441–52.
  • Lauer, A.C., Elder, J.T., Weiner, N.D. (1997). Evaluation of the hairless rat as a model for in vivo percutaneous absorbtion. J Pharm Sci. 86:13–8.
  • Li, L., Hoffman, R.M. (1995). The feasibility of targeted selective gene therapy of the hair follicle. Nat Med. 1:705–6.
  • Mansouri, S., Lavigne, P., Corsi, K., Benderdour, M., Beaumont, E., Fernandes, J. (2004). Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm. 57:1–8.
  • Mao, H.Q., Roy, K., Troung-Le, V.L., Janes, K.A., Lin, K.Y., Wang, Y., August, J.T., Leong, K.W. (2001). Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Contr Rel. 70:399–421.
  • Meykadeh, N., Mirmohammadsadegh, A., Wang, Z., Basner-Tschakarian, E., Hengge, U.R. (2005). Topical application of plasmid DNA to mouse and human skin. J Mol Med. 83:897–903.
  • Özbaş-Turan, S., Aral, C., Kabasakal, L., Keyer-Uysal, M., Akbuğa, J. (2003). Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery. J Pharm Pharmaceut Sci. 6:27–32.
  • Promega Corporation. Technical Bulletin. (2006). ß-Galactosidase enzyme assay system with reporter lysis buffer. Parts#TB097. 2800 Woods Hollow Road, Madison, WI 53711-5399, USA.
  • Raghavachari, N., Fahl, W.E. (2002). Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles. J Pharm Sci. 91:615–22.
  • Shi, Z., Curiel, D.T., Tang, D.C. (1999). DNA-based non-invasive vaccination onto the skin. Vaccine. 17:2136–41.
  • Vogel, J.C. (2000). Nonviral skin gene therapy. Human Gene Therapy. 11:2253–9.
  • Wraight, C.J., White, P.J. (2001). Antisense oligonucleotides in cutaneous therapy. Pharmacol Therapeut. 90:89–104.
  • Yu, W.H., Kashani-Sabet, M., Liggitt, D., Moore, D., Heath, T.D., Debs, R.J. (1999). Topical gene delivery to murine skin. J Invest Dermatol. 112:370–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.